LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients.

Life (Basel) · 2020 · PMC7555220 · PMID 32878005

Europe PMC DOI

hedged sentence

0.1530

closest p · 3.1× alpha

0.1530

boldest claim

The sentences

showed a trendp = 0.153not close (p > 0.1)

Among the 20 RC patients with available blood samples (MV and paired PV), those with high plasmatic–lincRNA-p21 expression in plasma obtained from MV ( Figure 4 a) showed a trend toward shorter DFS (NR versus 74.90 months, p = 0.153; Figure 4 c) and significantly shorter OS (NR versus 81.69 months, p = 0.032; Figure 4 d).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.